MediPharm Launches ‘Innovative’ Line Of CBD Products For Medical, Recreational Use

Cannabis producer MediPharm Labs Corp. (TSX: LABS) (OTC: MEDIF) said Thursday it will launch MediPharm Labs-branded products covering both the  medical and recreational markets in Canada.

MediPharm Labs CBD REGULAR FORMULA 25 is a 25-to-1, high-CBD, low THC oil with around 25mg/Ml of CBD to 1mg of THC.

The product is crafted with full-spectrum cannabis concentrate produced at MediPharm’s facility. 

Other products from the new line are expected to hit the shelves in the upcoming weeks and months, the company said. 

“We …

Full story available on Benzinga.com

More MediPharm Launches 'Innovative' Line Of CBD Products For Medical, Recreational Use